+9%
PER HOUR
Higher adjusted odds of hospital mortality per hour of antibiotic delay in sepsis.
LIU ET AL. / 2017PMID 28345952
Economic & Healthcare Rationale
Delayed bacterial confirmation impacts patients, hospitals, and healthcare costs.
12-72 HRS
CULTURE TURNAROUNDPMID 30135230
01
Patient Impact
1 in 3
SEPTIC SHOCK MORTALITY
U.S. sepsis encounters involving septic shock resulting in death, 2021.
AHRQ / 2024AHRQ 2024
1.27M
AMR DEATHS
Global deaths directly attributable to bacterial antimicrobial resistance in 2019.
LANCET / 2022PMID 35065702
02
Hospital Impact
8 DAYS
SHORTER STAY
23.3 versus 15.3 hospital days after rapid diagnostics plus stewardship in resistant Gram-negative bacteremia.
PEREZ ET AL. / 2014PMID 24841135
16.7M
HOSPITAL DAYS
Annual U.S. inpatient days associated with sepsis, 2021.
AHRQ / 2024AHRQ 2024
2.5M
INPATIENT STAYS
U.S. sepsis-related hospitalizations, 2021.
AHRQ / 2024AHRQ 2024
03
Economic Impact
PER DAY / PER CASE
$550
PER HOSPITAL DAY
Institution-specific inpatient-day cost assumption used in a rapid-testing economic model.
ROTH ET AL. / 2022PMID 35203725
$2,439
LOWER COST PER CASE
Observed cost difference per bloodstream infection after rapid testing plus stewardship.
PATEL ET AL. / 2017PMID 27795335
$26,298
LOWER COST PER SURVIVOR
Reduced hospital cost per inpatient survivor in resistant Gram-negative bacteremia.
PEREZ ET AL. / 2014PMID 24841135
ANNUAL / NATIONAL
$2.34M
ESTIMATED ANNUAL SAVINGS
Hospital-level estimate following rapid testing and stewardship.
PATEL ET AL. / 2017PMID 27795335
$2.4M
ESTIMATED ANNUAL SAVINGS
Hospital-level estimate in resistant Gram-negative bacteremia.
PEREZ ET AL. / 2014PMID 24841135
$52.1B
U.S. HOSPITAL COSTS
Aggregate national sepsis-related hospitalization costs in 2021.
AHRQ / 2024AHRQ 2024